NCT00083408View on ClinicalTrials.gov

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 1998

Study Completion Date

May 31, 2005

Conditions
Multiple Myeloma
Interventions
DRUG

Pamidronate

DRUG

Thalidomide

Trial Locations (1)

72205

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00083408 - Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide | Biotech Hunter | Biotech Hunter